0
Abstract: Poster Presentations |

THE EFFECTS OF INHALED TIOTROPIUM BROMIDE ON LUNG INFLAMMATION IN BRONCHIAL ASTHMA FREE TO VIEW

Pankaj Sayal, MBBS, MD*; Tulsi Adhikari, PhD; V. K. Vijayan, MBBS, MD
Author and Funding Information

Vallabhbhai Patel Chest Institute, New Delhi, India


Chest


Chest. 2007;132(4_MeetingAbstracts):509a. doi:10.1378/chest.132.4_MeetingAbstracts.509a
Text Size: A A A
Published online

Abstract

PURPOSE: Tiotropium bromide is an anticholinergic agent. Its potential for inhibiting airway inflammatory mechanisms has been postulated by in vitro studies, but the relevance of these to clinical practice is not known. By evaluating the cell profile in the Bronchoalveolar lavage (BAL) fluid and pulmonary function tests (PFT) both pre-tiotropium and post-tiotropium administration, the effects of this drug in bronchial asthma can be studied.

METHODS: In a Double-blind randomized control trial, BAL and PFT were performed on 20 subjects of bronchial asthma and 9 controls, the asthmatics were then divided into two sub-groups: Group I subjects after their pre-treatment BAL received inhalational tiotropium bromide+fluticasone dipropionate and salmetrol combination and Group II subjects after their pre-treatment BAL received inhalational Placebo+fluticasone dipropionate and salmetrol combination.Subjects were on medication for six to eight weeks and then underwent re-bronchoalveolar lavage and PFT. The data were analyzed using paired and independent ‘t’ tests.

RESULTS: There were 11 and 9 subjects in group I and II respectively apart from 9 controls. BAL and PFT were repeated after (7 weeks+5 days). There was a significant decrease(p<0.01) in BAL total cells in Group-I (post-tiotropium). The absolute macrophage count also showed a significant decline(p<0.01) in group-I, but the same were not significant on an inter-group analysis. PFT revealed a significant decline in FEV1 %predicted(p<0.01), FVC/FEV1 %predicted(p<0.01) and FEF25-75 % predicted(p<0.01) and TLC(p<0.05) in both groups, but the same were not significant on an inter-group analysis.

CONCLUSION: The observation of a decrease in BAL total cell count and absolute macrophage count in the lower respiratory tracts of subjects receiving tiotropium bromide may indicate that tiopropium bromide may have an antiinflammatory effect in bronchial asthma.

CLINICAL IMPLICATIONS: The study emphasizes the need for further evaluation of inhaled tiotropium bromide as an anti-inflammatory drug in bronchial asthma.

DISCLOSURE: Pankaj Sayal, No Financial Disclosure Information; No Product/Research Disclosure Information

Wednesday, October 24, 2007

12:30 PM - 2:00 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543